AR032614A1 - CONTROLLED ORAL ADMINISTRATION SYSTEM FOR DAILY INTAKE OF CIPROFLOXACINE - Google Patents

CONTROLLED ORAL ADMINISTRATION SYSTEM FOR DAILY INTAKE OF CIPROFLOXACINE

Info

Publication number
AR032614A1
AR032614A1 ARP010100957A ARP010100957A AR032614A1 AR 032614 A1 AR032614 A1 AR 032614A1 AR P010100957 A ARP010100957 A AR P010100957A AR P010100957 A ARP010100957 A AR P010100957A AR 032614 A1 AR032614 A1 AR 032614A1
Authority
AR
Argentina
Prior art keywords
oral administration
ciprofloxacine
administration system
daily intake
agent
Prior art date
Application number
ARP010100957A
Other languages
Spanish (es)
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of AR032614A1 publication Critical patent/AR032614A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una formula contenida en una tableta diaria para administracion oral a humanos para la liberacion controlada de Ciprofloxacina farmacéuticamente efectiva, desde alrededor de 0.1% hasta alrededor de 8.0% de un agente viscolizante y/o un agente de gelacion, alrededor de 5.0% hasta alrededor de 15% de un agente generador de gas (efervescencia), y alrededor de 3.0% hasta alrededor de 15% de un agente de expansion, estando dichos porcentajes en relacion de peso/peso del compuesto.A formula contained in a daily tablet for oral administration to humans for the controlled release of pharmaceutically effective Ciprofloxacin, from about 0.1% to about 8.0% of a viscolizing agent and / or a gelling agent, about 5.0% to about 15% of a gas generating agent (effervescence), and about 3.0% to about 15% of an expanding agent, said percentages being in relation to weight / weight of the compound.

ARP010100957A 2000-03-03 2001-02-28 CONTROLLED ORAL ADMINISTRATION SYSTEM FOR DAILY INTAKE OF CIPROFLOXACINE AR032614A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51788700A 2000-03-03 2000-03-03

Publications (1)

Publication Number Publication Date
AR032614A1 true AR032614A1 (en) 2003-11-19

Family

ID=24061635

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010100957A AR032614A1 (en) 2000-03-03 2001-02-28 CONTROLLED ORAL ADMINISTRATION SYSTEM FOR DAILY INTAKE OF CIPROFLOXACINE

Country Status (31)

Country Link
EP (1) EP1263409A1 (en)
JP (1) JP2003525229A (en)
KR (1) KR20030009374A (en)
CN (1) CN1420763A (en)
AP (2) AP2001002084A0 (en)
AR (1) AR032614A1 (en)
AU (1) AU3589701A (en)
BG (1) BG107055A (en)
BR (1) BR0108958A (en)
CA (1) CA2400950A1 (en)
CZ (1) CZ20022883A3 (en)
DO (1) DOP2001000130A (en)
EA (1) EA200200914A1 (en)
EC (1) ECSP013952A (en)
EE (1) EE200200497A (en)
GT (1) GT200100033A (en)
HN (1) HN2001000038A (en)
HR (1) HRP20020715A2 (en)
HU (1) HUP0204417A3 (en)
IL (1) IL151553A0 (en)
IS (1) IS6532A (en)
MX (1) MXPA02008568A (en)
NO (1) NO20024108L (en)
NZ (1) NZ520927A (en)
OA (1) OA12381A (en)
PE (1) PE20011113A1 (en)
PL (1) PL365071A1 (en)
SK (1) SK12542002A3 (en)
WO (1) WO2001064183A1 (en)
YU (1) YU66202A (en)
ZA (1) ZA200206764B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109806237A (en) * 2019-03-13 2019-05-28 悦康药业集团上海制药有限公司 A kind of Ciprofloxacin Lactate effervescent tablet and preparation method thereof

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
US20030229101A1 (en) * 2002-06-06 2003-12-11 Sherman Bernard Charles Tablets comprising ciprofloxacin hydrochloride
DE10351448A1 (en) 2003-11-04 2005-06-09 Bayer Healthcare Ag Flavor-containing drug formulations with improved pharmaceutical properties
EP1745775B1 (en) * 2005-07-19 2008-05-28 Ethypharm Gastroretentive formulations and manufacturing process thereof.
EP1880722B1 (en) * 2006-07-19 2010-03-17 Tabuk Pharmaceutical Manufacturing Co. Pharmaceutical compositions of ciprofloxacin
WO2016115253A1 (en) 2015-01-14 2016-07-21 The Regents Of The University Ofcolordo, A Body Corporate Insulin mimotopes and methods of using the same
EP3419669A4 (en) * 2016-02-23 2019-10-30 Matripharm International Inc. Dual-rate release formulation with high drug loading
AU2017236977B2 (en) 2016-03-24 2022-05-26 Immunomolecular Therapeutics, Inc. Methods of treating autoimmune disease
US11052060B2 (en) 2018-02-12 2021-07-06 The Regents Of The University Of Colorado, A Body Corporate Compounds and methods for treating autoimmunity
US11013707B2 (en) 2018-03-23 2021-05-25 The Regents Of The University Of Colorado, A Body Corporate Administration of oral methyldopa

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
JPH0624959A (en) * 1991-10-04 1994-02-01 Bayer Yakuhin Kk Medice release solid pharmaceutical preparation of gastric suspending type sustained
DE4406424A1 (en) * 1994-02-28 1995-08-31 Bayer Ag Expandable dosage forms
DE19839057A1 (en) * 1998-08-28 2000-03-02 Koch Berthold Purge air controller for a drying device for compressed air
EA004443B1 (en) * 1998-09-14 2004-04-29 Рэнбакси Лабораториз Лимитед Pharmaceutical formulation for controlled release of ciprofloxacin for one administration per day

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109806237A (en) * 2019-03-13 2019-05-28 悦康药业集团上海制药有限公司 A kind of Ciprofloxacin Lactate effervescent tablet and preparation method thereof

Also Published As

Publication number Publication date
OA12381A (en) 2004-09-06
CZ20022883A3 (en) 2003-04-16
KR20030009374A (en) 2003-01-29
WO2001064183A1 (en) 2001-09-07
IS6532A (en) 2002-08-28
EP1263409A1 (en) 2002-12-11
CN1420763A (en) 2003-05-28
HN2001000038A (en) 2005-03-23
NO20024108D0 (en) 2002-08-28
AU3589701A (en) 2001-09-12
BG107055A (en) 2003-06-30
MXPA02008568A (en) 2003-02-24
HRP20020715A2 (en) 2004-12-31
AP2002002627A0 (en) 2002-09-30
IL151553A0 (en) 2003-04-10
PL365071A1 (en) 2004-12-27
AP1485A (en) 2005-10-31
NO20024108L (en) 2002-10-25
GT200100033A (en) 2001-10-25
HUP0204417A2 (en) 2003-05-28
CA2400950A1 (en) 2001-09-07
PE20011113A1 (en) 2001-10-14
YU66202A (en) 2005-09-19
EA200200914A1 (en) 2003-02-27
ZA200206764B (en) 2003-03-04
BR0108958A (en) 2003-09-30
HUP0204417A3 (en) 2005-03-29
NZ520927A (en) 2003-06-30
DOP2001000130A (en) 2004-03-31
SK12542002A3 (en) 2003-05-02
JP2003525229A (en) 2003-08-26
AP2001002084A0 (en) 2001-03-31
EE200200497A (en) 2004-02-16
ECSP013952A (en) 2002-04-23

Similar Documents

Publication Publication Date Title
ATE386508T1 (en) SOLID ORAL DOSAGE FORM CONTAINING AN ABSORPTION ENHANCER
ATE333265T1 (en) RAPIDLY DISSOLVING SOLID DOSAGE FORMS FOR ORAL APPLICATION
BR0215184A (en) orally active taxane derivative pharmaceutical compositions having increased bioavailability
NO993520L (en) Dosage forms and methods for better erectile dysfunction
RS20110564A2 (en) Diurnal formulation of oxycodone
ES2172239T3 (en) OSMOTIC SYSTEM OF LIBERATION OF PHARMACOS.
PT833618E (en) PHARMACEUTICAL FORM SOLID FOR ORAL USE
BR0112054A (en) Micelle-forming composition, and methods for administration and protection of a therapeutic agent
NO20025621D0 (en) Sustained release pharmaceutical composition for parenteral administration of hydrophilic compounds
PE20030602A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING A MACROLIDE
MY118371A (en) Tetrahydrolipstatin containing compositions
CO5280073A1 (en) COMPOSITIONS
TR199801861T2 (en) Pharmaceutically useful compositions.
AR032614A1 (en) CONTROLLED ORAL ADMINISTRATION SYSTEM FOR DAILY INTAKE OF CIPROFLOXACINE
BR0209283A (en) Method for the manufacture of a low dosage pharmaceutical composition having uniform drug distribution and potency
RS50768B (en) Dosage regimen and pharmaceutical composition for emergency contraception
DE50203456D1 (en) DEUTERATED 3-PIPERIDINOPROPIOPHENONE AND MEDICAMENTS CONTAINING SUCH COMPOUNDS
AR011919A1 (en) FORMULATION IN TABLETS OR SWALLOWING CAPSULES OF PARACETAMOL (N-ACETIL-P-AMINOFENOL) AND PROCEDURE TO PREPARE IT
MY129314A (en) Pharmaceutical composition comprising sumatriptan
MXPA03005221A (en) Pharmaceutical dronedarone composition for parenteral administration.
MXPA06000332A (en) Novel solid pharmaceutical composition comprising amisulpride.
SE0001916D0 (en) Novel formulation
AR039162A1 (en) VENLAFAXINA FORMULATIONS OF EXTENDED LIBERATION
UY26605A1 (en) CONTROLLED ORAL ADMINISTRATION SYSTEM FOR DAILY INGESTION OF CIPROFLOXACIN
SV2003000335A (en) CONTROLLED ORAL ADMINISTRATION SYSTEM FOR DAILY INTAKE OF CIPROFLOXACINE

Legal Events

Date Code Title Description
FA Abandonment or withdrawal